IL-21 Protein (AA 32-162)
-
- Target Alle IL-21 (IL21) Proteine anzeigen
- IL-21 (IL21) (Interleukin 21 (IL21))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 32-162
-
Spezies
- Human
-
Quelle
- Escherichia coli (E. coli)
- Verwendungszweck
- Human IL-21 Protein
- Sequenz
- Gln32-Ser162
- Produktmerkmale
- Recombinant Human IL-21 Protein is expressed from E.coli without tag.It contains Gln32-Ser162.
- Reinheit
- > 95 % as determined by Tris-Bis PAGE
- Sterilität
- 0.22 μm filtered
- Endotoxin-Niveau
- Less than 1EU per μg by the LAL method.
- Biological Activity Comment
- Immobilized Human IL-21, No Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Human IL-21R, hFc Tag with the EC50 of 63.6ng/ml determined by ELISA. See testing image for detail.
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in 20 mM NaAc, 150 mM NaCl ( pH 5.5).
- Buffer
- Lyophilized from 0.22μm filtered solution in 20 mM NaAc, 150 mM NaCl ( pH 5.5). Normally 8 % trehalose is added as protectant before lyophilization.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- IL-21 (IL21) (Interleukin 21 (IL21))
- Andere Bezeichnung
- IL-21 (IL21 Produkte)
- Hintergrund
- Interleukin-21 (IL-21), produced predominantly by CD4 T cells and natural killer T (NKT) cells, is a newly discovered member of the common γ-chain family of cytokines. It has been implicated in many immunological processes and has been linked to autoimmune diseases, allergies and other inflammatory diseases.
- Molekulargewicht
- 15.4 kDa same as Tris-Bis PAGE result.
- UniProt
- Q9HBE4-1
- Pathways
- JAK-STAT Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
-